Analysis of the STAT3 interactome using in-situ biotinylation and SILAC

Journal of Proteomics

Volumn 94, Issue , 2013, Pages 370-386

  Blumert, Conny ^a,b   Kalkhof, Stefan ^c   Brocke Heidrich, Katja ^a   Kohajda, Tibor ^c   von Bergen, Martin ^c,d   Horn, Friedemann ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^c HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

In situ biotinylation; Interactome; SILAC; STAT3

Indexed keywords

AMINO ACID; CARRIER PROTEINS AND BINDING PROTEINS; COATOMER PROTEIN ALPHA; COATOMER PROTEIN BETA; COATOMER PROTEIN DELTA; CORTACTIN; FILAMIN A; HISTONE DEACETYLASE 2; INITIATION FACTOR 3B; INITIATION FACTOR 3C; INITIATION FACTOR 4 GAMMA 1; INITIATION FACTOR 4B; INITIATION FACTOR 4E BINDING PROTEIN 2; INITIATION FACTOR 5; INTERLEUKIN 6 RECEPTOR ALPHA; KINESIN 1; PROTEIN BAX; RUVB LIKE 1 PROTEIN; RUVB LIKE 2 PROTEIN; SAP30 BINDING PROTEIN; SEGMENT POLARITY PROTEIN DISHEVELED HOMOLOG DVL 2; SEPTIN 11; SEPTIN 9; SORTING NEXIN 1; STABLE ISOTOPE; STAT3 PROTEIN; STREPTAVIDIN; TALIN 1; TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 4; TRANSLATIONAL ACTIVATOR GCN1; UNCLASSIFIED DRUG;

ARTICLE; BIOFILTRATION; BIOTINYLATION; CELL CULTURE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTO ONCOGENE C CRK; STABLE ISOTOPE LABELING WITH AMINO ACIDS IN CELL CULTURE; TRANSACTIVATION;

CDK; CYCLIN-DEPENDENT KINASE; EPO; ERYTHROPOIETIN; IL-6; IN-SITU BIOTINYLATION; INTERACTOME; INTERLEUKIN-6; LC-MS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; SILAC; STABLE ISOTOPE LABELING WITH AMINO ACIDS IN CELL CULTURE; STAT3;

BIOTINYLATION; HEK293 CELLS; HUMANS; NEOPLASM PROTEINS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; STAT3 TRANSCRIPTION FACTOR;

EID: 84886845190     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.08.021     Document Type: Article

References (77)

1. Shuai K., Ziemiecki A., Wilks A.F., Harpur A.G., Sadowski H.B., Gilman M.Z., et al. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 1993, 366:580-583.
2. Wegenka U.M., Buschmann J., Lütticken C., Heinrich P.C., Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 1993, 13:276-288.
3. Lütticken C., Wegenka U.M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 1994, 263:89-92.
4. Yuan J., Wegenka U.M., Lütticken C., Buschmann J., Decker T., Schindler C., et al. The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol Cell Biol 1994, 14:1657-1668.
5. Bromberg J., Darnell J.E. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000, 19:2468-2473.
6. Stepkowski S.M., Chen W., Ross J.A., Nagy Z.S., Kirken R.A. STAT3: an important regulator of multiple cytokine functions. Transplantation 2008, 85:1372-1377.
7. Decker T., Kovarik P. Serine phosphorylation of STATs. Oncogene 2000, 19:2628-2637.
8. Yuan Z.-L., Guan Y.-J., Chatterjee D., Chin Y.E. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 2005, 307:269-273.
9. Ray S., Boldogh I., Brasier A.R. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Gastroenterology 2005, 129:1616-1632.
10. Decker T., Kovarik P. Transcription factor activity of STAT proteins: structural requirements and regulation by phosphorylation and interacting proteins. Cell Mol Life Sci 1999, 55:1535-1546.
11. Lufei C., Ma J., Huang G., Zhang T., Novotny-Diermayr V., Ong C.T., et al. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J 2003, 22:1325-1335.
12. Rödel B., Tavassoli K., Karsunky H., Schmidt T., Bachmann M., Schaper F., et al. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J 2000, 19:5845-5855.
13. Dabir S., Kluge A., Dowlati A. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent. Mol Cancer Res 2009, 7:1854-1860.
14. Proietti C.J., Béguelin W., Flaqué M.C.D., Cayrol F., Rivas M.A., Tkach M., et al. Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer. Steroids 2011, 76:381-392.
15. Gough D.J., Corlett A., Schlessinger K., Wegrzyn J., Larner A.C., Levy D.E. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009, 324:1713-1716.
16. Mathivanan S., Periaswamy B., Gandhi T.K.B., Kandasamy K., Suresh S., Mohmood R., et al. An evaluation of human protein-protein interaction data in the public domain. BMC Bioinformatics 2006, 7(Suppl. 5):S19.
17. Verma N.K., Dourlat J., Davies A.M., Long A., Liu W.-Q., Garbay C., et al. STAT3-stathmin interactions control microtubule dynamics in migrating T-cells. J Biol Chem 2009, 284:12349-12362.
18. Howard P.K., Shaw J., Otsuka A.J. Nucleotide sequence of the birA gene encoding the biotin operon repressor and biotin holoenzyme synthetase functions of Escherichia coli. Gene 1985, 35:321-331.
19. Schatz P.J. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (N Y) 1993, 11:1138-1143.
20. Cull M.G., Schatz P.J. Biotinylation of proteins in vivo and in vitro using small peptide tags. Methods Enzymol 2000, 326:430-440.
21. Parrott M.B., Barry M.A. Metabolic biotinylation of recombinant proteins in mammalian cells and in mice. Mol Ther 2000, 1:96-104.
22. Boer Ed, Rodriguez P., Bonte E., Krijgsveld J., Katsantoni E., Heck A., et al. Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A 2003, 100:7480-7485.
23. Rodriguez P., Braun H., Kolodziej K.E., Boer Ed, Campbell J., Bonte E., et al. Isolation of transcription factor complexes by in vivo biotinylation tagging and direct binding to streptavidin beads. Methods Mol Biol 2006, 338:305-323.
24. Kim J., Cantor A.B., Orkin S.H., Wang J. Use of in vivo biotinylation to study protein-protein and protein-DNA interactions in mouse embryonic stem cells. Nat Protoc 2009, 4:506-517.
25. Sinz A., Kalkhof S., Ihling C. Mapping protein interfaces by a trifunctional cross-linker combined with MALDI-TOF and ESI-FTICR mass spectrometry. J Am Soc Mass Spectrom 2005, 16(12):1921-1931.
26. Viens A., Mechold U., Lehrmann H., Harel-Bellan A., Ogryzko V. Use of protein biotinylation in vivo for chromatin immunoprecipitation. Anal Biochem 2004, 325:68-76.
27. Chapman-Smith A., Cronan J.E. The enzymatic biotinylation of proteins: a post-translational modification of exceptional specificity. Trends Biochem Sci 1999, 24:359-363.
28. Boulon S., Ahmad Y., Trinkle-Mulcahy L., Verheggen C., Cobley A., Gregor P., et al. Establishment of a protein frequency library and its application in the reliable identification of specific protein interaction partners. Mol Cell Proteomics 2010, 9:861-879.
29. Rigaut G., Shevchenko A., Rutz B., Wilm M., Mann M., Séraphin B. A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol 1999, 17:1030-1032.
30. Trinkle-Mulcahy L., Boulon S., Lam Y.W., Urcia R., Boisvert F.-M., Vandermoere F., et al. Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J Cell Biol 2008, 183:223-239.
31. Hutchins J.R.A., Toyoda Y., Hegemann B., Poser I., Hériché J.-K., Sykora M.M., et al. Systematic analysis of human protein complexes identifies chromosome segregation proteins. Science 2010, 328:593-599.
32. Ranish J.A., Brand M., Aebersold R. Using stable isotope tagging and mass spectrometry to characterize protein complexes and to detect changes in their composition. Methods Mol Biol 2007, 359:17-35.
33. Vermeulen M., Hubner N.C., Mann M. High confidence determination of specific protein-protein interactions using quantitative mass spectrometry. Curr Opin Biotechnol 2008, 19:331-337.
34. Hubner N.C., Bird A.W., Cox J., Splettstoesser B., Bandilla P., Poser I., et al. Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions. J Cell Biol 2010, 189:739-754.
35. Keshava Prasad T.S., Goel R., Kandasamy K., Keerthikumar S., Kumar S., Mathivanan S., et al. Human protein reference database-2009 update. Nucleic Acids Res 2009, 37:D767-D772.
36. Mechold U., Gilbert C., Ogryzko V. Codon optimization of the BirA enzyme gene leads to higher expression and an improved efficiency of biotinylation of target proteins in mammalian cells. J Biotechnol 2005, 116:245-249.
37. Gerhartz C., Heesel B., Sasse J., Hemmann U., Landgraf C., Schneider-Mergener J., et al. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation. J Biol Chem 1996, 271:12991-12998.
38. Ng D.C.H., Lin B.H., Lim C.P., Huang G., Zhang T., Poli V., et al. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol 2006, 172:245-257.
39. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991, 19:2499.
40. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
41. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
42. Müller S.A., Kohajda T., Findeiss S., Stadler P.F., Washietl S., Kellis M., et al. Optimization of parameters for coverage of low molecular weight proteins. Anal Bioanal Chem 2010, 398:2867-2881.
43. Goettsch C., Kliemt S., Sinningen K., von Bergen M., Hofbauer L., Kalkhof S. Quantitative proteomics reveals novel functions of osteoclast-associated receptor in STAT signaling and cell adhesion in human endothelial cells. J Mol Cell Cardiol 2012, 53(6):829-837.
44. Kliemt S., Lange C., Otto W., Hintze V., Möller S., von Bergen M., et al. Sulfated hyaluronan containing collagen matrices enhance cell-matrix-interaction, endocytosis, and osteogenic differentiation of human mesenchymal stromal cells. J Proteome Res 2012.
45. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008, 26:1367-1372.
46. Cox J., Matic I., Hilger M., Nagaraj N., Selbach M., Olsen J.V., et al. A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat Protoc 2009, 4:698-705.
47. Safran M., Dalah I., Alexander J., Rosen N., Iny Stein T., Shmoish M., et al. GeneCards version 3: the human gene integrator. Database (Oxford) 2010, 2010:baq020.
48. McDowall M.D., Scott M.S., Barton G.J. PIPs: human protein-protein interaction prediction database. Nucleic Acids Res 2009, 37:D651-D656.
49. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
50. Lütticken C., Coffer P., Yuan J., Schwartz C., Caldenhoven E., Schindler C., et al. Interleukin-6-induced serine phosphorylation of transcription factor APRF: evidence for a role in interleukin-6 target gene induction. FEBS Lett 1995, 360:137-143.
51. Brocke-Heidrich K., Kretzschmar A.K., Pfeifer G., Henze C., Löffler D., Koczan D., et al. Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation. Blood 2004, 103:242-251.
52. Ray S., Lee C., Hou T., Boldogh I., Brasier A.R. Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution. Nucleic Acids Res 2008, 36:4510-4520.
53. Icardi L., Lievens S., Mori R., Piessevaux J., Cauwer Ld, Bosscher Kd, et al. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. FASEB J 2012, 26:240-249.
54. Zheng P., Zhong Q., Xiong Q., Yang M., Zhang J., Li C., et al. QUICK identification and SPR validation of signal transducers and activators of transcription 3 (Stat3) interacting proteins. J Proteomics 2012, 75:1055-1066.
55. Hemmann U., Gerhartz C., Heesel B., Sasse J., Kurapkat G., Grötzinger J., et al. Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation. J Biol Chem 1996, 271:12999-13007.
56. Giraud S., Hurlstone A., Avril S., Coqueret O. Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene. Oncogene 2004, 23:7391-7398.
57. Hou T., Ray S., Brasier A.R. The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression. J Biol Chem 2007, 282:37091-37102.
58. Brasier A.R. Expanding role of cyclin dependent kinases in cytokine inducible gene expression. Cell Cycle 2008, 7:2661-2666.
59. Zhang J., Chen F., Li W., Xiong Q., Yang M., Zheng P., et al. 14-3-3ζ interacts with stat3 and regulates its constitutive activation in multiple myeloma cells. PLoS One 2012, 7:e29554.
60. Shah M., Patel K., Fried V.A., Sehgal P.B. Interactions of STAT3 with caveolin-1 and heat shock protein 90 in plasma membrane raft and cytosolic complexes. Preservation of cytokine signaling during fever. J Biol Chem 2002, 277:45662-45669.
61. Lufei C., Koh T.H., Uchida T., Cao X. Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene 2007, 26:7656-7664.
62. Bauer K., Kretzschmar A.K., Cvijic H., Blumert C., Löffler D., Brocke-Heidrich K., et al. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells. Oncogene 2009, 28:2784-2795.
63. Selbach M., Mann M. Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK). Nat Methods 2006, 3:981-983. [Epub 2006 Oct 29].
64. Tsuruma R., Ohbayashi N., Kamitani S., Ikeda O., Sato N., Muromoto R., et al. Physical and functional interactions between STAT3 and KAP1. Oncogene 2008, 27:3054-3059.
65. Zhang Y., Iratni R., Erdjument-Bromage H., Tempst P., Reinberg D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 1997, 89:357-364.
66. Li J.-F., Liu L.-D., Ma S.-H., Che Y.-C., Wang L.-C., Dong C.-H., et al. HTRP - an immediate-early gene product induced by HSV1 infection in human embryo fibroblasts, is involved in cellular co-repressors. J Biochem 2004, 136:169-176.
67. Grzenda A., Lomberk G., Zhang J.-S., Urrutia R. Sin3: master scaffold and transcriptional corepressor. Biochim Biophys Acta 2009, 1789:443-450.
68. O'Flaherty E., Kaye J. TOX defines a conserved subfamily of HMG-box proteins. BMC Genomics 2003, 4:13.
69. Wilkinson B., Chen J.Y.-F., Han P., Rufner K.M., Goularte O.D., Kaye J. TOX: an HMG box protein implicated in the regulation of thymocyte selection. Nat Immunol 2002, 3:272-280.
70. Ruiz-Narváez E.A., Rosenberg L., Cozier Y.C., Cupples L.A., Adams-Campbell L.L., Palmer J.R. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. Cancer Epidemiol Biomarkers Prev 2010, 19:1320-1327.
71. Yuan S.H., Qiu Z., Ghosh A. TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci U S A 2009, 106:2909-2914.
72. Dittmer S., Kovacs Z., Yuan S.H., Siszler G., Kögl M., Summer H., et al. TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J Cell Sci 2011, 124:252-260.
73. Kretzschmar A.K., Dinger M.C., Henze C., Brocke-Heidrich K., Horn F. Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells. Biochem J 2004, 377:289-297.
74. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4:P3.
75. Bandyopadhyay S., Chiang C.-y., Srivastava J., Gersten M., White S., Bell R., et al. A human MAP kinase interactome. Nat Methods 2010, 7:801-805.
76. Du X.-L., Yang H., Liu S.-G., Luo M.-L., Hao J.-J., Zhang Y., et al. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma. Oncogene 2009, 28:3714-3722.
77. Oda A., Wakao H., Fujihara M., Ozaki K., Komatsu N., Tanaka S., et al. Thrombopoietin and interleukin-2 induce association of CRK with STAT5. Biochem Biophys Res Commun 2000, 278:299-305.